Peter D. Nicholas JR., M.D.
Specialist
- Medicare participating
At a glance
- Medical school
- Temple University School of Medicine (1977)
- Years since graduation
- 49
- In the NPI registry since
- 2005
- Medicare patients seen, 2024
- 523
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1977Medical school: Temple University School of Medicine
- 2005Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Specialist primary
PA license MD021072E
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Geisinger Medical Center Danville, PA
- Reading Hospital West Reading, PA
- Penn State Health St. Joseph Reading, PA
- Schuylkill Medical Center - South Jackson Street Pottsville, PA
- Geisinger St. Luke's Hospital Orwigsburg, PA
Medical groups
- Phoenix Rehabilitation and Health Services Inc (2,800 clinicians)
- H2 Rehabilitation Extension Services LLC (163 clinicians)
- Arthritis and Osteoporosis Center, Inc. (7 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 523
- Services billed
- 72,446
- Patients’ average age
- 76
| Service | Times | Patients |
|---|---|---|
| Injection, tocilizumab, 1 mg | 30,507 | 31 |
| Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 24,000 | 24 |
| Injection, denosumab, 1 mg | 16,800 | 183 |
| Injection, golimumab, 1 mg, for intravenous use | 7,550 | 14 |
| Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 5,800 | 24 |
| Injection, infliximab, excludes biosimilar, 10 mg | 3,530 | 18 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 1,970 | 175 |
| Established patient office or other outpatient visit, 30-39 minutes | 607 | 361 |
| Established patient office or other outpatient visit, 20-29 minutes | 484 | 338 |
| Injection of drug or substance under skin or into muscle | 324 | 192 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Prednisone Other prescribers in Wyomissing, PA | 438 |
| Methotrexate (methotrexate sodium) Other prescribers in Wyomissing, PA | 272 |
| Hydroxychloroquine Sulfate Other prescribers in Wyomissing, PA | 258 |
| Methylprednisolone Other prescribers in Wyomissing, PA | 250 |
| Tramadol Hcl Other prescribers in Wyomissing, PA | 178 |
| Meloxicam Other prescribers in Wyomissing, PA | 125 |
| Hydrocodone-Acetaminophen (hydrocodone/acetaminophen) Other prescribers in Wyomissing, PA | 123 |
| Omeprazole Other prescribers in Wyomissing, PA | 100 |
| Gabapentin Other prescribers in Wyomissing, PA | 88 |
| Ibandronate Sodium Other prescribers in Wyomissing, PA | 72 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 12 companies reported 61 payments worth $1,403 in total to this clinician.
| Amgen Inc. | $411 |
|---|---|
| AstraZeneca Pharmaceuticals LP | $205 |
| Janssen Biotech, Inc. | $202 |
| AbbVie Inc. | $201 |
| GlaxoSmithKline, LLC. | $99.89 |
| UCB, Inc. | $74.52 |
| Novartis Pharmaceuticals Corporation | $74.11 |
| Ani Pharmaceuticals, Inc. | $46.50 |
| Food and Beverage | $1,208 |
|---|---|
| Education | $195 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Janssen Biotech, Inc. May 15, 2025 | Education TREMFYA · Immunology · in-kind | $99.95 |
| Janssen Biotech, Inc. Oct 23, 2025 | Education TREMFYA · Immunology · in-kind | $94.99 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.